XHR Stock Analysis: Xenia Hotels & Resorts | NYSE
REIT - Hotel & Motel | NYSE, USA | Market Cap: 1.895m USD | 12M Return: 52.2% | US9840171030 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 16.5M
EPS Trend: 80.4%
Qual. Beats: 2
Rev. Trend: 93.4%
Qual. Beats: -1
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Xenia Hotels & Resorts, Inc. (NYSE: XHR) is a self-advised and self-administered real estate investment trust (REIT) that invests in luxury and upper upscale hotels and resorts across the United States, with a focus on the top 25 lodging markets and key leisure destinations. The company owns 29 hotels and resorts comprising 8,783 rooms across 14 states, with properties operated or licensed by major hospitality brands including Marriott, Hyatt, Kimpton, Fairmont, Loews, Hilton, and Davidson. Xenia was incorporated in 2007, is headquartered in Orlando, and has been publicly traded since its February 2015 IPO.
As a hotel and resort REIT, Xenia generates revenue primarily through ownership of lodging real estate, typically structured as triple-net leases or management agreements with hotel operators, where the REIT collects rents or fees while third-party brands run day-to-day operations. REITs are required to distribute at least 90% of their taxable income to shareholders as dividends, making them a common income-oriented investment vehicle.
- Luxury hotel RevPAR growth drives revenue and margins higher
- Federal Reserve rate cuts reduce REIT borrowing costs
- Group and convention demand recovery boosts occupancy and ADR
| Net Income: -7.10m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 2.48 > 1.0 |
| NWC/Revenue: 11.28% < 20% (prev 9.07%; Δ 2.21% < -1%) |
| CFO/TA 0.07 > 3% & CFO 181.9m > Net Income -7.10m |
| Net Debt (1.26b) to EBITDA (204.4m): 6.17 < 3 |
| Current Ratio: 2.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (92.7m) vs 12m ago -8.72% < -2% |
| Gross Margin: -9.64% > 18% (prev 25.32%; Δ -34.96% > 0.5%) |
| Asset Turnover: 39.08% > 50% (prev 37.40%; Δ 1.68% > 0%) |
| Interest Coverage Ratio: 0.90 > 6 (EBIT TTM 75.8m / Interest Expense TTM 84.4m) |
| A: 0.05 (Total Current Assets 232.6m - Total Current Liabilities 109.3m) / Total Assets 2.72b |
| B: -0.26 (Retained Earnings -696.0m / Total Assets 2.72b) |
| C: 0.03 (EBIT TTM 75.8m / Avg Total Assets 2.80b) |
| D: 0.71 (Book Value of Equity 1.11b / Total Liabilities 1.55b) |
| Altman-Z'' = 0.39 = B |
| DSRI: 1.01 (Receivables 36.5m/35.6m, Revenue 1.09b/1.08b) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.58 (AQ_t 0.03 / AQ_t-1 0.04) |
| SGI: 1.02 (Revenue 1.09b / 1.08b) |
| TATA: -0.07 (NI -7.10m - CFO 181.9m) / TA 2.72b) |
| Beneish M = -3.26 (Cap -4..+1) = AA |
As of October 21, 2026, the stock is trading at USD 19.54 with a total of 614,736 shares traded. Over the past week, the price has changed by +5.85%, over one month by +10.25%, over three months by -6.68% and over the past year by +52.20%.
Current recommended Stop Loss: 18.90 (which is 3.3% or 1.4 ATR below the current price).
Xenia Hotels & Resorts has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy XHR.
- StrongBuy: 3
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 21.1 | 8% |
P/E Forward = 63.2911
P/S = 1.7344
P/B = 1.4811
Revenue TTM = 1.09b USD
EBIT TTM = 75.8m USD
EBITDA TTM = 204.4m USD
Long Term Debt = 1.36b USD (from longTermDebt, last quarter)
Short Term Debt = 12.0m USD (from shortTermDebt, last quarter)
Debt = 1.37b USD (from shortLongTermDebtTotal, last quarter) + Leases 7.60m
Net Debt = 1.26b USD (calculated: Debt 1.37b - CCE 112.4m)
Enterprise Value = 3.16b USD (1.90b + Debt 1.37b - CCE 112.4m)
Interest Coverage Ratio = 0.90 (Ebit TTM 75.8m / Interest Expense TTM 84.4m)
EV/FCF = 27.33x (Enterprise Value 3.16b / FCF TTM 115.5m)
FCF Yield = 3.66% (FCF TTM 115.5m / Enterprise Value 3.16b)
FCF Margin = 10.57% (FCF TTM 115.5m / Revenue TTM 1.09b)
Net Margin = -0.65% (Net Income TTM -7.10m / Revenue TTM 1.09b)
Gross Margin = -9.64% ((Revenue TTM 1.09b - Cost of Revenue TTM 1.20b) / Revenue TTM)
Gross Margin QoQ = 6.21% (prev 7.94%)
Tobins Q-Ratio = 1.16 (Enterprise Value 3.16b / Total Assets 2.72b)
Interest Expense / Debt = 6.14% (Interest Expense 84.4m / Debt 1.37b)
Taxrate = 2.04% (1.39m / 68.3m)
NOPAT = 74.3m (EBIT 75.8m * (1 - 2.04%))
Current Ratio = 2.13 (Total Current Assets 232.6m / Total Current Liabilities 109.3m)
Debt / Equity = 1.24 (Debt 1.37b / totalStockholderEquity, last quarter 1.11b)
Debt / EBITDA = 6.17 (Net Debt 1.26b / EBITDA 204.4m)
Debt / FCF = 10.92 (Net Debt 1.26b / FCF TTM 115.5m)
Total Stockholder Equity = 1.14b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.25% (Net Income -7.10m / Total Assets 2.72b)
RoE = -0.62% (Net Income TTM -7.10m / Total Stockholder Equity 1.14b)
RoCE = 3.03% (EBIT 75.8m / Capital Employed (Equity 1.14b + L.T.Debt 1.36b))
RoIC = 2.89% (NOPAT 74.3m / Invested Capital 2.57b)
WACC = 7.20% (E(1.90b)/V(3.27b) * Re(8.06%) + D(1.37b)/V(3.27b) * Rd(6.14%) * (1-Tc(0.02)))
Discount Rate = 8.06% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -90.45 | Cagr: -4.30%
[DCF] Terminal Value 77.97% ; FCFF base≈89.6m ; Y1≈102.7m ; Y5≈151.2m
[DCF] Fair Price = 10.98 (EV 2.27b - Net Debt 1.26b = Equity 1.01b / Shares 92.2m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 80.44 | EPS CAGR: 55.08% | SUE: 3.52 | # QB: 2
Revenue Correlation: 93.37 | Revenue CAGR: 2.62% | SUE: -1.01 | # QB: -1
EPS current Quarter (2026-09-30): EPS=-0.14 | Chg30d=+6.67% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=-0.11 | Chg30d=-122.00% | Revisions=+0% | GrowthEPS=-104.7% | GrowthRev=+4.5%
EPS next Year (2027-12-31): EPS=0.64 | Chg30d=+0.00% | Revisions=-25% | GrowthEPS=+677.3% | GrowthRev=+2.6%
[Analyst] Revisions Ratio: -25% (up=0, down=1)